UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS

Sormani, MP; Kappos, L; Radue, E-W; Cohen, J; Barkhof, F; Sprenger, T; Meier, DP; ... De Stefano, N; + view all (2017) Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. Multiple Sclerosis Journal , 23 (5) pp. 656-664. 10.1177/1352458516659550. Green open access

[thumbnail of Sormani_Defining_brain_volume.pdf]
Preview
Text
Sormani_Defining_brain_volume.pdf - Accepted Version

Download (211kB) | Preview

Abstract

OBJECTIVE: To define values of normalized brain volume (NBV) that can be categorized as low, medium, or high, according to baseline characteristics of relapsing-remitting multiple sclerosis (RRMS) patients. METHODS: Expected NBV (eNBV) was calculated for each patient based on age, disease duration, sex, baseline Expanded Disability Status Scale (EDSS), and T2-lesion volume, entering these variables into a multiple regression model run on 2342 RRMS patients (pooled FREEDOMS/FREEDOMS-II population). According to the difference between their observed NBV and their eNBV, patients were classified as having low NBV, medium NBV, or high NBV. We evaluated whether these NBV categories were clinically meaningful by assessing correlation with disability worsening. RESULTS: The distribution of differences between observed NBV and eNBV was used to categorize patients as having low NBV, medium NBV or high NBV. Taking the high-NBV group as reference, the hazard ratios (HRs) for 2-year disability worsening, adjusted for treatment effect, were 1.23 (95% confidence interval (CI): 0.92–1.63, p = 0.16) for the medium NBV and 1.75 (95% CI: 1.26–2.44, p = 0.001) for the low NBV. The predictive value of NBV groups was preserved over 4 years. Treatment effect appeared more evident in low-NBV patients (HR = 0.58) than in medium-NBV (HR = 0.72) and in high-NBV (HR = 0.80) patients; however, the difference was not significant (p = 0.57). CONCLUSION: RRMS patients can be categorized into disability risk groups based on individual eNBV values according to baseline demographics and clinical characteristics.

Type: Article
Title: Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS
Open access status: An open access version is available from UCL Discovery
DOI: 10.1177/1352458516659550
Publisher version: https://doi.org/10.1177/1352458516659550
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Disability worsening, multiple sclerosis, normalized brain volume, fingolimod
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
URI: https://discovery.ucl.ac.uk/id/eprint/10049403
Downloads since deposit
271Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item